Daniel DiCapua, MD, FAAN (Neurology)
Associate Professor of Neurology, Chief, Neuromuscular MedicineCards
Appointments
Additional Titles
Director, Fellowship Program, Neuromuscular Medicine
Contact Info
Appointments
Additional Titles
Director, Fellowship Program, Neuromuscular Medicine
Contact Info
Appointments
Additional Titles
Director, Fellowship Program, Neuromuscular Medicine
Contact Info
About
Titles
Associate Professor of Neurology, Chief, Neuromuscular Medicine
Director, Fellowship Program, Neuromuscular Medicine
Biography
Dr. Daniel DiCapua is an Associate Professor of Clinical Neurology, Clinical Chief of Neuromuscular Medicine and Director of the Neuromuscular Fellowship Program. He received his MD from Temple University School of Medicine (2005) and completed Residency at Yale-New Haven Hospital (2009) and Fellowship at Yale University School of Medicine (2010). He specializes Neuromuscular Medicine and specifically in Myasthenia Gravis and Neuropathy.
Appointments
Neurology
Associate Professor on TermPrimary
Other Departments & Organizations
- Myasthenia Gravis Program
- Neurology
- Neuromuscular Medicine
- Neurophysiology
- Nowak Lab
- Yale Medicine
- Yale Ventures
Education & Training
- Fellowship
- Yale University School of Medicine (2010)
- Residency
- Yale-New Haven Hospital (2009)
- Internship
- Yale Primary Care (2006)
- MD
- Temple University School of Medicine (2005)
- BS
- University of Connecticut (2000)
Research
Research at a Glance
Yale Co-Authors
Publications Timeline
Benison Keung, MD
Richard Nowak, MD, MS
Huned Patwa, MD
Kevin O'Connor, PhD
Babar Khokhar, MD, MBA, FAAN (Neurology)
Sasha Zivkovic, MD, PhD
Publications
2024
Late Onset of Severe Demyelinating Peripheral Neuropathy in a 62-Year-Old African American Woman
Zivkovic S, DiCapua D. Late Onset of Severe Demyelinating Peripheral Neuropathy in a 62-Year-Old African American Woman. Journal Of Clinical Neuromuscular Disease 2024, 25: 152-156. PMID: 38441936, DOI: 10.1097/cnd.0000000000000481.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsAfrican American womenAmerican womenSevere carpal tunnel syndromeCarpal tunnel syndromeHistory of gaitSensorimotor demyelinating polyneuropathyDemyelinating sensorimotor polyneuropathyEarly onset of symptomsSevere demyelinating peripheral neuropathyWalking difficultiesOnset of symptomsFamily historyNatural history studiesCharcot-Marie-Tooth diseaseGenetic testingTunnel syndromeHomozygous pathogenic mutationDistal sensory lossExamination scoresCharcot-Marie-ToothElectrodiagnostic testingDemyelinating polyneuropathySensorimotor polyneuropathySH3TC2 geneUnwitnessed fall
2019
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study
Murai H, Uzawa A, Suzuki Y, Imai T, Shiraishi H, Suzuki H, Okumura M, O’Brien F, Wang J, Fujita K, Utsugisawa K, Group I, Mazia C, Wilken M, Barroso F, Saba J, Rugiero M, Bettini M, Chaves M, Vidal G, Garcia A, De Bleecker J, Van den Abeele G, de Koning K, De Mey K, Mercelis R, Mahieu D, Wagemaekers L, Van Damme P, Depreitere A, Schotte C, Smetcoren C, Stevens O, Van Daele S, Vandenbussche N, Vanhee A, Verjans S, Vynckier J, D'Hondt A, Tilkin P, de Siqueira Carvalho A, Brockhausen I, Feder D, Ambrosio D, César P, Melo A, Ribeiro R, Rocha R, Rosa B, Veiga T, da Silva L, Engel M, Geraldo J, da Penha Ananias Morita M, Coelho E, Paiva G, Pozo M, Prando N, Torres D, Butinhao C, Duran G, da Silva T, Gonçalves L, Pazetto L, Fialho T, Volpe L, Duca L, Oliveira A, Andrade A, Annes M, Silva L, Lino V, Pinto W, Assis N, Carrara F, Miranda C, Souza I, Fernandes P, Siddiqi Z, Phan C, Narayan J, Blackmore D, Mallon A, Roderus R, Watt E, Junkerova J, Kurkova B, Reguliova K, Zapletalova O, Pitha J, Novakova I, Tyblova M, Jurajdova I, Wolfova M, Andersen H, Harbo T, Vinge L, Krogh S, Mogensen A, Vissing J, Højgaard J, Witting N, Autzen A, Pedersen J, Eralinna J, Laaksonen M, Oksaranta O, Harrison T, Eriksson J, Rozsa C, Horvath M, Lovas G, Matolcsi J, Szabo G, Jakab G, Szabadosne B, Antonini G, Di Pasquale A, Garibaldi M, Morino S, Troili F, Fionda L, Filla A, Costabile T, Marano E, Saccà F, Fasanaro A, Marsili A, Puorro G, Mantegazza R, Antozzi C, Bonanno S, Camera G, Locatelli A, Maggi L, Pasanisi M, Campanella A, Evoli A, Alboini P, D'Amato V, Iorio R, Kanai T, Kawaguchi N, Mori M, Kaneko Y, Kanzaki A, Kobayashi E, Masaki K, Matsuse D, Matsushita T, Uehara T, Shimpo M, Jingu M, Kikutake K, Nakamura Y, Sano Y, Nagane Y, Kamegamori I, Tsuda T, Fujii Y, Futono K, Ozawa Y, Mizugami A, Saito Y, Morikawa M, Samukawa M, Kamakura S, Miyawaki E, Mitazaki T, Motomura M, Mukaino A, Yoshimura S, Asada S, Yoshida S, Amamoto S, Kobashikawa T, Koga M, Maeda Y, Takada K, Takada M, Tsurumaru M, Yamashita Y, Akiyama T, Narikawa K, Tano O, Tsukita K, Kurihara R, Meguro F, Fukuda Y, Sato M, Funaka S, Kawamura T, Makamori M, Takahashi M, Taichi N, Hasuike T, Higuchi E, Kobayashi H, Osakada K, Tsuda E, Shimohama S, Hayashi T, Hisahara S, Kawamata J, Murahara T, Saitoh M, Suzuki S, Yamamoto D, Ishiyama Y, Ishiyama N, Noshiro M, Takeyama R, Uwasa K, Yasuda I, van der Kooi A, de Visser M, Gibson T, Casasnovas C, Aguilo M, Homedes-Pedret C, Palacios N, Porras L, Santamaria V, Lazaro A, Tejedor E, Salcedo P, Fernandez-Fournier M, Ruiz P, de Rivera F, Sastre M, Gamez J, Sune P, Salvado M, Gili G, Mazuela G, Illa I, Vicente E, Diaz-Manera J, Gutierrez L, Garcia R, Vidal N, Arribas-Ibar E, Piehl F, Hietala A, Bjarbo L, Sengun I, Meherremova A, Ozcelik P, Balkan B, Tuga C, Ugur M, Erdem-Ozdamar S, Bekircan-Kurt C, Acar N, Yilmaz E, Caliskan Y, Orsel G, Efendi H, Aydinlik S, Cavus H, Kutlu A, Becerikli G, Semiz C, Tun O, Terzi M, Dogan B, Onar M, Sen S, Cavdar T, Veske A, Norwood F, Dimitriou A, Gollogly J, Mahdi-Rogers M, Seddigh A, Sokratous G, Maier G, Sohail F, Jacob S, Sadalage G, Torane P, Brown C, Shah A, Sathasivam S, Arndt H, Davies D, Watling D, Amato A, Cochrane T, Salajegheh M, Roe K, Amato K, Toska S, Wolfe G, Silvestri N, Patrick K, Zakalik K, Katz J, Miller R, Engel M, Forshew D, Bravver E, Brooks B, Plevka S, Burdette M, Cunningham S, Sanjak M, Kramer M, Nemeth J, Schommer C, Tierney S, Juel V, Guptill J, Hobson-Webb L, Massey J, Beck K, Carnes D, Loor J, Anderson A, Pascuzzi R, Bodkin C, Kincaid J, Snook R, Guingrich S, Micheels A, Chaudhry V, Corse A, Mosmiller B, Kelley A, Ho D, Srinivasan J, Vytopil M, Jara J, Ventura N, Scala S, Carter C, Donahue C, Herbert C, Weiner E, Alam S, McKinnon J, Haar L, McKinnon N, Alcon K, McKenna K, Sattar N, Daniels K, Jeffery D, Freimer M, Hoyle J, Kissel J, Agriesti J, Chelnick S, Mezache L, Pineda C, Muharrem F, Karam C, Khoury J, Marburger T, Kaur H, Dimitrova D, Gilchrist J, Agrawal B, Elsayed M, Kohlrus S, Andoin A, Darnell T, Golden L, Lokaitis B, Seelback J, Muppidi S, Goyal N, Sakamuri S, So Y, Paulose S, Pol S, Welsh L, Bhavaraju-Sanka R, Gonzales A, Dishman L, Jones F, Gonzalez A, Padilla P, Saklad A, Silva M, Kazamel M, Alsharabati M, Lu L, Nozaki K, Mumfrey-Thomas S, Woodall A, Mozaffar T, Cash T, Goyal N, Roy G, Mathew V, Maqsood F, Minton B, Jones H, Rosenfeld J, Garcia R, Echevarria L, Garcia S, Pulley M, Aranke S, Berger A, Shah J, Shabbir Y, Smith L, Varghese M, Gutmann L, Gutmann L, Jerath N, Nance C, Swenson A, Olalde H, Kressin N, Sieren J, Barohn R, Dimachkie M, Glenn M, McVey A, Pasnoor M, Statland J, Wang Y, Liu T, Emmons K, Jenci N, Locheke J, Fondaw A, Johns K, Rico G, Walsh M, Herbelin L, Hafer-Macko C, Kwan J, Zilliox L, Callison K, Young V, DiSanzo B, Naunton K, Benatar M, Bilsker M, Sharma K, Cooley A, Reyes E, Michon S, Sheldon D, Steele J, Howard J, Karam C, Chopra M, Traub R, Vu T, Katzin L, McClain T, Harvey B, Hart A, Huynh K, Beydoun S, Chilingaryan A, Doan V, Droker B, Gong H, Karimi S, Lin F, McClain T, Pokala K, Shah A, Tran A, Akhter S, Malekniazi A, Tandan R, Hehir M, Waheed W, Lucy S, Weiss M, Distad J, Strom S, Downing S, Kim B, Nowak R, Dicapua D, Keung B, Kumar A, Patwa H, Robeson K, Yang I, Nye J, Vu H. Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study. Journal Of The Neurological Sciences 2019, 407: 116419. PMID: 31698177, DOI: 10.1016/j.jns.2019.08.004.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsSafety of eculizumabMyasthenia gravisCaucasian patientsAnti-acetylcholine receptor antibody-positive refractoryTerminal complement inhibitor eculizumabOpen-label extension studyMyasthenia Gravis ActivitiesQuantitative Myasthenia GravisGeneralized myasthenia gravisOpen-label extensionComplement inhibitor eculizumabLong-term efficacyMyasthenia Gravis QualityMyasthenia Gravis CompositeExtension baselineWeek 52Safety profileSubgroup analysisJapanese patientsDaily livingEculizumabGravisExtension studyPatientsREGAIN study
2016
Simulation of Neurological Emergencies for Milestones-Based Learning and Assessment (P2.357)
Loomis C, Robeson K, DiCapua D, Dodge K, Evans L, Moadel T, Cruz L, Moeller J. Simulation of Neurological Emergencies for Milestones-Based Learning and Assessment (P2.357). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.p2.357.Peer-Reviewed Original ResearchCitations
2015
The Relationship Between Cerebrospinal Fluid Protein Levels and Electrophysiologic Abnormalities in Guillain-Barré Syndrome (P7.091)
Homafar H, Lakraj A, Nowak R, Robeson K, Goldstein J, Patwa H, DiCapua D. The Relationship Between Cerebrospinal Fluid Protein Levels and Electrophysiologic Abnormalities in Guillain-Barré Syndrome (P7.091). Neurology 2015, 84 DOI: 10.1212/wnl.84.14_supplement.p7.091.Peer-Reviewed Original Research
2014
Is the Rituximab Response in Acetylcholine Receptor Autoantibody Myasthenia Gravis Durable? (S36.009)
Robeson K, Keung B, DiCapua D, Goldstein J, O'Connor K, Nowak R. Is the Rituximab Response in Acetylcholine Receptor Autoantibody Myasthenia Gravis Durable? (S36.009). Neurology 2014, 82 DOI: 10.1212/wnl.82.10_supplement.s36.009.Peer-Reviewed Original ResearchBilateral Gluteal Dyskinesia: Discussion of a Rare Movement Disorder
Sorokin A, Mittal S, DiCapua D, Jabbari B. Bilateral Gluteal Dyskinesia: Discussion of a Rare Movement Disorder. Tremor And Other Hyperkinetic Movements 2014, 4: 221. DOI: 10.5334/tohm.206.Peer-Reviewed Original ResearchMuscle Contraction; Overview
DiCapua D. Muscle Contraction; Overview. 2014, 185-189. DOI: 10.1016/b978-0-12-385157-4.00669-2.Peer-Reviewed Original ResearchCitations
2013
Novel mutations in the CLCN1 gene of myotonia congenita: 2 case reports.
Lakraj AA, Miller G, Vortmeyer AO, Khokhar B, Nowak RJ, DiCapua DB. Novel mutations in the CLCN1 gene of myotonia congenita: 2 case reports. The Yale Journal Of Biology And Medicine 2013, 86: 101-6. PMID: 23483815, PMCID: PMC3584487.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsMyotonia congenitaClinical presentationPatient 1Salient clinical featuresCLCN1 geneSarcolemmal chloride conductanceClinical featuresPatient 2Muscle relaxationMuscle biopsyElectrical myotoniaGenetic testingCLCN1 mutationsCongenitaCommon typeNovel mutationsPatientsChloride conductanceRecessive formUnidentified mutationsMyotoniaGene sequencingPresentationMutationsBiopsy
2012
Autoantibodies Produced at the Site of Tissue Damage Provide Evidence of Humoral Autoimmunity in Inclusion Body Myositis
Ray A, Amato AA, Bradshaw EM, Felice KJ, DiCapua DB, Goldstein JM, Lundberg IE, Nowak RJ, Ploegh HL, Spooner E, Wu Q, Willis SN, O’Connor K. Autoantibodies Produced at the Site of Tissue Damage Provide Evidence of Humoral Autoimmunity in Inclusion Body Myositis. PLOS ONE 2012, 7: e46709. PMID: 23071619, PMCID: PMC3465259, DOI: 10.1371/journal.pone.0046709.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsInclusion body myositisHumoral immune responseImmune responsePlasma cellsTissue damageBody myositisAntibody-secreting plasma cellsCell linesSingle plasma cellsMajor intermediate filament proteinMuscle tissueIBM patientsHumoral autoimmunityInflammatory myopathiesHuman-derived cell linesIBM muscleMuscle tissue sectionsMuscle tissue homogenatesMuscle diseaseTissue homogenatesTissue sectionsIntermediate filament proteinsMyositisAutoantibodiesDiseaseLong Term Efficacy of Rituximab in Patients with MuSK Auto-Antibody Myasthenia Gravis (PD6.007)
Nowak R, Keung B, Robeson K, DiCapua D, Goldstein J. Long Term Efficacy of Rituximab in Patients with MuSK Auto-Antibody Myasthenia Gravis (PD6.007). Neurology 2012, 78: pd6.007-pd6.007. DOI: 10.1212/wnl.78.1_meetingabstracts.pd6.007.Peer-Reviewed Original Research
Clinical Care
Overview
Clinical Specialties
Fact Sheets
Neuropathy
Learn More on Yale MedicineMyasthenia Gravis
Learn More on Yale MedicineMuscular Dystrophy
Learn More on Yale MedicinePeripheral Neuropathy
Learn More on Yale Medicine
Board Certifications
Neuromuscular Medicine
- Certification Organization
- AB of Psychiatry & Neurology
- Latest Certification Date
- 2021
- Original Certification Date
- 2011
Neurology
- Certification Organization
- AB of Psychiatry & Neurology
- Latest Certification Date
- 2019
- Original Certification Date
- 2009
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews
News
Get In Touch
Contacts
Locations
Yale-Neurophysiology Lab
Lab
Yale Physicians Building
800 Howard Avenue, Ste Lower Level
New Haven, CT 06519
Appointments
203.688.2495Fax
203.688.3109Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.